Picking stocks at small cap stage for potential 100x. Medical field.
California, USA
Joined October 2012
- Tweets42.7K
- Following2K
- Followers16.1K
- Likes135K
My port now covers the new wave of medicine that will replace the “keep you sick” companies we have now-
1) $HIMS - distribution, peptides, primary care within minutes. And for cheap.
2) $ABCL - frontier of antibody therapy discovery, and development. This is the new direction of pharma, and Abcellera is the best at it.
3) $PRME - prime gene editing, best tech in the space. Looking to potentially cure 89% of genetic diseases at the source.
4) $NAUT - mapping the proteome. Also best tech in the space. Essential to improving medicine development, lowering the “shot in the dark” aspect of drug discovery. This will improve the efficiency, and accuracy of finding the best new drugs. And ideally prevent wasteful failed clinical trials.
5) $ENHA - on the frontier of performance medicine. Running clinical trials on elite athletes, and gathering data on athletes at a level that has never been done before in relation to enhancers. Simultaneously providing a major platform for athletes to safely enhance, and fill a market of yearly Olympic type games. Which can expand to many disciplines including mma, boxing etc,
BPC-157 would help boomers the most. A 67 y/o I recommended to get on BPC-157 was also recommended hand surgery by his doctor. He also could not throw a baseball because he had shoulder issues.
Today I got a text that he throws a baseball with his grandson, and his hand pain is completely gone. And that’s after just a few doses. $HIMS $ENHA
